Navigation Links
IVD (In Vitro Diagnostic) Market by (Product Type, Applications and Technology) Worth $69.1 Billion by 2017 - New Report by MarketsandMarkets
Date:8/29/2013

(PRWEB) August 29, 2013

IVD (In Vitro Diagnostic) Market research report focuses on the various levels of analysis, namely, industry, market shares, value chain, PESTEL analysis, and company profiles, which together comprise and augment the basic views on the competitive landscape, emerging and high growth segments of in vitro diagnostic (molecular diagnostics & point of care testing), emerging technologies, high growth regions and countries and their respective regulatory policies, government initiative, drivers, restraints, and opportunities.

Browse 178 market data tables and 50 figures spread through 421 pages and in-depth TOC on “In Vitro Diagnostic (IVD) Market [Instruments, Reagents & Data Management Systems] [Technique (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Haematology) & Applications (Diabetes, Infectious Diseases, Cancer & Cardiology)] Systems, End Users] - Forecast To 2017.” Download a free sample report for IVD (In Vitro Diagnostic) Market.

Early buyers will receive 10% customization on this report.

In vitro diagnostics has been an area of significant innovation over the last decade, translating the practice of medicine into process, throughout the world. The Americas and Europe are saturated markets for IVD reagents and devices. The developing regions including BRIC (Brazil, Russia, India, and China) countries are expected to form the new revenue pockets for this market. The rising economies of these countries are the major driver for the growth of the IVD market. In addition, the large population, increasing incidences of chronic diseases, growing demand for quality medical care, increase in healthcare spending, and government initiatives are some of the other key factors fuelling the growth of IVD market in these regions. For instance, the Brazilian government provides free healthcare services to its citizens in government hospitals; the federal government funds around 65% of public healthcare expenditure and the municipal and local sources fund the rest of the expenditure.

In order to take advantage of the favorable conditions in developing economies and to cater to high demand of IVD technologies, a number of IVD companies are investing in these emerging countries. For instance, in June 2011, Hologic, Inc. acquired TCT International Co. Ltd., a distributor of medical products in China, for $135 million. The acquisition strengthened Hologic’s brand leadership in the cervical cancer screening market in China.

Among the BRIC countries, China’s IVD market is estimated to grow at the highest CAGR in the next five years. Fast-paced economy, public screening initiatives, and investments in healthcare infrastructure are the main drivers contributing to the growth of the IVD market in China. The players in the IVD market are expanding their facilities in China in order to meet this anticipated demand. In addition to China, the Indian IVD market also demonstrated a robust growth over the past few years. On the basis of market size, it now ranks among the top ten countries in the global IVD market. India’s evolving IVD market offers remarkable growth opportunities due to factors such as the increase in healthcare affordability, growing incidence of lifestyle diseases (diabetes and cardiovascular problems), and the large population size. The growth has been witnessed particularly in segments such as clinical chemistry and molecular diagnostics.

The other emerging countries such as Brazil, Russia, and Mexico also are growing IVD markets that are attracting leading companies. The combined effort of government and public sectors to increase healthcare awareness has enabled Asia and the LATAM region to become an attractive market for IVD manufacturers and suppliers.

The molecular diagnostic segment is expected to witness tremendous growth in the near future. Aging population, a concurrent escalation in the prevalence of chronic diseases, and the need for detection of such diseases at early stages are the key factors stimulating the market growth. Several big market players such as Siemens Healthcare, Abbott Laboratories, Inc., and Roche Diagnostics Limited are trying to increase their market share in the molecular diagnostics segment. In addition, Immunochemistry, clinical chemistry, and hematology techniques are also observing double-digit growth in the market. Many in vitro diagnostics companies are investing in these high growth markets, in order to gain more profits and capture increasing share in the market.

Browse related reports

Aptamers Market - Technology Trend Analysis By Applications - Therapeutics, Diagnostics, Biosensors, Drug Discovery, Biomarker Discovery, Research Applications with Market Landscape Analysis - Global Forecasts to 2018
http://www.marketsandmarkets.com/Market-Reports/aptamers-technology-market-1167.html

Lab Automation Market by Equipment & Software (Automated Liquid Handling & Robotics, Microplate Readers, LIMS and Automated Storage), and Applications (Drug Discovery, Clinical Diagnostics, Genomics, Proteomics) – Trends & Global Forecasts to 2017
http://www.marketsandmarkets.com/Market-Reports/lab-automation-market-1158.html

About MarketsandMarkets

MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.

MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals; including agriculture, advanced materials, automotives and transportation, banking and financial services, biotechnology, chemicals, consumer goods, telecommunications and IT, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, aerospace & defense.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Contact:
Mr. Rohan
North - Dominion Plaza
17304 Preston Road
Suite 800, Dallas, TX 75252
Tel: +1-888-6006-441
Email: sales(at)marketsandmarkets(dot)com
Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare-it
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets

Read the full story at http://www.prweb.com/releases/ivd-in-vitro-diagnostics/market/prweb11073779.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. BUSM in vitro study identifies potential combination therapy for breast cancer
2. In vitro studies assess the optimal concentration of propolis as a radioprotector
3. Case Western Reserve researchers create short-term memories in-vitro
4. In vitro study finds digested formula, but not breast milk, is toxic to cells
5. Canada In Vitro Diagnostics Market Analysis and Forecasts to 2017 in New Research Report at RnRMarketResearch.com
6. New study on Hepatitis C drug treatment in vivo and in vitro
7. ViVitro Labs Adds Real-Time Wear Tester to Their Line of Cardiovascular Device Testing Equipment
8. Some Oral Contraceptives May Reduce Pregnancy Chances in In Vitro Fertilization (IVF), According to New Research by CHR
9. Researchers identify novel approach to create red blood cells, platelets in vitro
10. Univ. of Maryland review finds mixed results for acupuncture to improve in vitro fertilization rates
11. In Vitro Diagnostics Market Will Reach USD 1.1 Billion by 2018: Transparency Market Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... ... 08, 2016 , ... Stephanie Hebert Insurance Agency, serving families ... new charity campaign. As part of their ongoing community involvement program, funds are ... that children deserve a voice, and in the spirit of neighbors helping neighbors ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... expansion into Canada to provide its range of unique and advantaged protective ... Quebec City that will provide bilingual customer service and marketing support. A new ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... announced today that nominations will be accepted February 8, 2016 through May ... , Awards include the Information Security Executive® of the Year, which recognizes ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... lower incidence rate of type 2 diabetes in the GrassrootsHealth cohort with substantially ... to make a change in public health,” states Carole Baggerly, Director of GrassrootsHealth, ...
(Date:2/8/2016)... , ... February 08, 2016 , ... The schedule ... in this country. The AutismOne 2016 Conference, which is being held May 25-29 at ... won’t hear elsewhere about helpful interventions and causes of chronic illness in children. , ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... , Feb. 8, 2016  Sangamo BioSciences, ... therapeutic genome editing, announced that the U.S. Food ... Investigational New Drug (IND) application for SB-318, a ... therapy for Mucopolysaccharidosis Type I (MPS I). The ... Sangamo to initiate a Phase 1/2 clinical study ...
(Date:2/8/2016)... February 8, 2016 ... published by Allied Market Research titled, "World ... Forecasts, 2014-2020", estimates the world synthetic biology market ... and sequencing technology segment would continue to lead ... tools segment, collectively, held around half of the ...
(Date:2/8/2016)... HOUSTON , 8. Februar 2016 /PRNewswire/ ... veröffentlichte heute eine Infografik mit dem Titel ... ganzen Welt), mit der der Krankheit gegenüber ... die dazu ermutigen soll, Medikamentenresistenz bei Epilepsie ... der allgemeinen Diskussion zu machen. Mithilfe der ...
Breaking Medicine Technology: